Regulacje i polityka gospodarcza · 03/12/1997
National Cancer Institute Seeks CRADA for Transgenic Mice Development
The National Cancer Institute is seeking a cooperative research and development agreement with a pharmaceutical or biotechnology company to develop and characterize transgenic mice expressing human cytochrome P450 genes CYP2D6 and CYP3A4, which may aid in drug development and risk assessment.